Cazzaniga ME, Galimberti S, Pepe FF, Cogliati V, et al. Metronomic (mCHT) vs standard (sCHT) chemotherapy as first-line treatment in HR+/HER2- Metastatic Breast Cancer (MBC) patients following failure of endocrine treatments. The matched control VICTOR-15 study. BMC Cancer 2026 Jan 20. doi: 10.1186/s12885-025-15482.
PMID: 41559627